Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle.

Study Objective: To examine the pharmacokinetics of zidovudine during the menstrual cycle in human immunodeficiency virus- (HIV-) positive women.

Design: Open, unblinded study.

Setting: A women's clinic for acquired immunodeficiency syndrome (AIDS) at a large medical center.